Characterization and in vivo biocompatibility analysis of synthetic hydroxyapatite compounds associated with magnetite nanoparticles for a drug delivery system in osteomyelitis treatment
Tài liệu tham khảo
Fournier, 2003, Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility, Biomaterials, 24, 3311, 10.1016/S0142-9612(03)00161-3
Nyska, 2014, Histopathology of biodegradable polymers: challenges in interpretation and the use of a novel compact MRI for biocompatibility evaluation, Polym. Adv. Technol., 25, 461, 10.1002/pat.3238
Y., 2008, A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response, J. Diabetes Sci. Technol., 2, 1003, 10.1177/193229680800200610
ISO document 10993
Borges, 2000, Hidroxiapatita sintética (HAP-91) como substituto ósseo em defeito experimental provocado no terço proximal da tíbia em cão: aspectos à microscopia eletrônica de transmissão, Arq. Bras. Med. Vet. Zootec., 52, 616, 10.1590/S0102-09352000000600011
Vital, 2006, Biocompatibilidade e comportamento de compósitos de hidroxiapatita em falha óssea na ulna de coelhos, Arq. Bras. Med. Vet. Zootec., 58, 175, 10.1590/S0102-09352006000200005
Sepúlveda, 2013, Composite synthetic hydroxyapatite 30%, in two physical states, as dermal filler, Rev. Ceres, 60, 458, 10.1590/S0034-737X2013000400003
Hiromoto, 2015, In vitro and in vivo biocompatibility and corrosion behaviour of a bioabsorbable magnesium alloy coated with octacalcium phosphate and hydroxyapatite, Acta Biomater., 11, 520, 10.1016/j.actbio.2014.09.026
Ahmadzadeh, 2017, A biological method for in-situ synthesis of hydroxyapatite-coated magnetite nanoparticles using Enterobacter aerogenes: characterization and acute toxicity assessments, Mater. Sci. Eng. C, 73, 220, 10.1016/j.msec.2016.12.012
Mahmoudia, 2009, Cell toxicity of superparamagnetic iron oxide nanoparticles, J. Colloid Interface Sci., 336, 510, 10.1016/j.jcis.2009.04.046
Watanabe, 2013, Effects of Fe3O4 magnetic nanoparticles on A549 cells, Int. J. Mol. Sci., 14, 15546, 10.3390/ijms140815546
Foroughi, 2016, In situ microemulsion synthesis of hydroxyapatite-MgFe2O4 nanocomposite as a magnetic drug delivery system, Mater. Sci. Eng. C Mater. Biol. Appl., 68, 774, 10.1016/j.msec.2016.07.028
Lai, 2009, The role of bloom index of gelatin on the interaction with retinal pigment epithelial cells, Int. J. Mol. Sci., 10, 3442, 10.3390/ijms10083442
Park, 2001, Platelet interactions with titanium: modulation of platelet activity by surface topography, Biomaterials, 22, 2671, 10.1016/S0142-9612(01)00009-6
Kikuchi, 2005, Platelet interactions with calciumphosphate-coated surfaces, Biomaterials, 26, 5285, 10.1016/j.biomaterials.2005.01.009
Gholipourmalekabadi, 2015, In vitro and in vivo evaluations of three-dimensional hydroxyapatite/silk fibroin nanocomposite scaffolds, Biotechnol. Appl. Biochem., 62, 441, 10.1002/bab.1285
Chow, 2009, Next generation calcium phosphate-based biomaterials, Dent. Mater. J., 28, 1, 10.4012/dmj.28.1
Carlo, 2009, Comparison of in vivo properties of hydroxyapatite polyhydroxybutyrate composites assessed for bone substitution, J. Craniofac. Surg., 20, 853, 10.1097/SCS.0b013e3181a14c30
Baumann, 1994, The acute phase response, Immunol. Today, 15, 74, 10.1016/0167-5699(94)90137-6
Tang, 1998, Mast cells mediate acute inflammatory responses to implanted biomaterials, Proc. Natl. Acad. Sci. U.S.A., 95, 8841, 10.1073/pnas.95.15.8841
Shen, 2001, The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces, J. Biomed. Mater. Res., 57, 336, 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
Carlo, 2007, Avaliação do efeito osteoindutor da hidroxiapatita e do biovidro implantados em tecido subcutâneo de cão, Rev. Ceres, 54, 492
Sepúlveda, 2013, Composite synthetic hydroxyapatite 30%, in two physical states, as dermal filler, Rev. Ceres, 60, 458, 10.1590/S0034-737X2013000400003
Amini, 2011, Short-term and long-term effects of orthopedic biodegradable implants, J. Long Term Eff. Med. Implants, 21, 93, 10.1615/JLongTermEffMedImplants.v21.i2.10
Nuss, 2008, Biocompatibility issues with modern implants in bone - a review for clinical orthopedics, Open Orthop. J., 2, 66, 10.2174/1874325000802010066
Abbas, 2012
Day, 2004, Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds, Biomaterials, 25, 5857, 10.1016/j.biomaterials.2004.01.043
Rucker, 2006, Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice, Biomaterials, 27, 5027, 10.1016/j.biomaterials.2006.05.033
Hoffbrand, 2001
Xie, 2012, Application of K/Sr co-doped calcium polyphosphate bioceramic as scaffolds for bone substitutes, J. Mater. Sci. Mater. Med., 23, 1033, 10.1007/s10856-012-4556-z